Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Massachusetts, United States
Countries of investment
  • USA
  • China
Investment stages
  • Seed
Industries
  • Health Tech
  • Biotechnology
  • AI
  • Data Science
About
Broadview Ventures accelerates cardiovascular technology development through targeted investments, focusing on improving human health with innovative solutions like Cardiosense's AI platform for predictive biomarkers.
Min check size
$100K
Max check size
$2M
Fund size
NPS

Investment Thesis

Broadview Ventures focuses on advancing startup companies in the cardiovascular and neurovascular disease space. They provide Seed and early stage funding via equity investments in companies developing innovative technologies for the diagnosis and treatment of cardiovascular disease and stroke.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a robust background in venture capital, the fund manager has successfully led over 50 investments across various sectors, including technology, healthcare, and sustainability. Their strategic focus is primarily on early-stage ventures in North America, where they leverage a data-driven approach to identify high-potential opportunities. The manager has achieved notable exits, reflecting a strong ability to navigate market dynamics and deliver value to stakeholders. Their operator-first mindset fosters deep partnerships with entrepreneurs, ensuring alignment and support throughout the growth journey.

Broadview Ventures Contacts Information

Primary contact

Secondary contact

Team

Tom Needham

Nichole Schiffer

Nichole Neal

Maria Berkman

Hewmun Lau

Christopher Colecchi

Benjamin Kreitman

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp